Two LHRH fusion proteins, thioredoxin and ovalbumin, each containing seven LHRH inserts were tested for their ability to inhibit estrous cycle activity. The objective was to evaluate immune and biological responses from alternating the two fusion proteins in an immunization schedule. One hundred ten heifers were divided equally into 11 groups. Two control groups consisted of either spayed or intact, untreated heifers. Heifers in the other nine groups were immunized on wk 0, 4, and 9. Treatments were immunizations of the same protein throughout or alternating the proteins in different booster sequences. Blood was collected weekly for 22 wk, and serum was assayed for concentrations of progesterone and titers of anti-LHRH. At slaughter, reproductive tracts were removed from each heifer and weighed. Heifers with >or=1 ng/mL of progesterone were considered to have a functional corpus luteum and thus to have estrous cycle activity. All LHRH-immunized groups of heifers had a smaller (P < 0.05) proportion of heifers showing estrous cycle activity after 6 wk than the intact, untreated control group. There was no difference in number of heifers cycling between the immunized groups and the spayed heifers during wk 9 to 22. Anti-LHRH did not differ among immunized groups during wk 1 to 9. Starting at wk 10 and continuing through the conclusion of the study, there was an overall difference among treatment groups for anti-LHRH (P < 0.05). Uterine weights differed among treatments (P < 0.05), with intact control animals having heavier uteri than all other groups (P < 0.05). Uterine weights were negatively correlated with maximum LHRH antibody binding (r = -0.44). In summary, the LHRH fusion proteins were as effective as surgical spaying in suppression of estrous cycle activity, but alternating the two proteins in an immunization schedule did not enhance the immunological or biological effectiveness of the vaccine.

This study evaluated the effectiveness of a LHRH fusion protein vaccine on endocrine changes, feedlot performance, and carcass quality of bulls compared with steers and hormone-implanted steers. Crossbred bulls (n = 30; mean weight, 179 +/- 4 kg; mean age, 130 +/- 2 d) were randomly assigned to three treatment groups: 1) castrated (castrated; n = 10); 2) castrated-implanted with trenbolone acetate (implanted; n = 10); and 3) immunized against a cocktail of recombinant fusion proteins, ovalbumin-LHRH-7 and thioredoxin-LHRH-7 (immunized bulls; n = 10). Blood was collected every 2 wk to evaluate antibody and hormone concentrations. Serum LHRH antibodies (P < 0.001) were detected in animals of the immunized group, which had reduced serum LH concentrations (P < 0.001) compared with the castrated groups and serum FSH concentrations, which did not decrease but were significantly different when compared with castrated and implanted animals. Serum testosterone concentrations in the immunized bulls were not different from the two castrated groups (P > 0.05) by d 60 after primary immunization. Initial mean scrotal circumference of the immunized bulls was 18.0 +/- 0.6 cm on d 0 and increased to 22.6 +/- 1.3 cm by d 310. No differences (P > 0.05) in ADG were observed among treatment groups. Immunized animals had an intermediate BW gain (P > 0.05) when compared with the castrates, whereas the castrated groups differed (P < 0.05) from each other. Carcass characteristics were similar (P < 0.05) among the three groups. Vaccinating bulls against a LHRH fusion protein cocktail suppressed LH and testosterone, which led to reduced testicular development and no bullock carcasses. Growth and carcass characteristics of the immunized animals were similar to the steers.

Thirty-six percent of American Wagyu bulls do not meet the current minimum standards set by the Society of Theriogenology for the breeding soundness exam. In contrast, only 15% of bulls of domestic breeds do not meet the minimum standards. Scrotal circumference measurements of Wagyu are smaller than those of other breeds. The objective of this research was to describe scrotal circumference of Wagyu bulls as it relates to age and BW. The data set consisted of 190 Wagyu bulls housed at two locations. One hundred forty-one bulls constituted the first set of data (location 1); scrotal circumference was measured one to six times per bull aged between 13 and 70 mo. Ninety-four of the bulls underwent semen evaluation for motility and morphology. Forty-nine bulls constituted the data set for which scrotal circumference and BW was measured one to nine times per bull between 5 and 21 mo of age (location 2). Mean scrotal circumference of bulls within each age group was as follows: 12 to 14 mo, 29.8 0.2 cm (mean +/- SE); 15 to 17 mo, 31.8 +/- 0.2 cm; 18 to 20 mo, 32.9 +/- 0.3 cm; 21 to 24 mo, 31.8 +/- 0.5 cm; and > 24 mo, 35.5 +/- 0.2 cm. Both age and BW were highly correlated to scrotal circumference (r = 0.81 and 0.82, respectively). Within each age group, there were a percentage of bulls that did not meet the minimum standard for scrotal circumference set by the Society of Theriogenology. The percentages were as follows: 12 to 14 mo, 46%; 15 to 17 mo, 25%; 18 to 20 mo, 33%; 21 to 24 mo, 42%; and > 24 mo, 32%. Morphology and motility were > 50% each in 91% of the bulls between ages 12 and 20 mo at location 1. Based on these data, it is recommended that Wagyu bulls be evaluated with the breed-specific minimum standards for scrotal circumference of 26 cm from 12 to 14 mo, 29 cm from 15 to 17 mo, and 30 cm from 18 to 20 mo of age.

A recombinant luteinizing hormone-releasing hormone (LHRH) fusion protein was evaluated for its effectiveness in suppression of estrus in heifers. Eight heifers were randomly assigned to two equal treatment groups. Treatments consisted of recombinant ovalbumin-LHRH-7 or recombinant ovalbumin (control). This recombinant chimeric fusion protein consisted of ovalbumin with seven LHRH peptides (ovalbumin-LHRH-7). The plasmid for this protein was expressed in E. coli and was collected and purified as an insoluble protein. One milligram of the respective proteins was suspended in 2 mL of Z-Max adjuvant and administered by intramammary injection three times at 7-wk intervals. Luteinizing hormone-releasing hormone antibody binding was elevated in heifers treated with ovalbumin-LHRH-7 compared to ovalbumin-treated heifers (P < .05). Serum progesterone concentrations (< 1 ng/mL) indicate that the estrous cycle of the four heifers treated with ovalbumin-LHRH-7 was suppressed for a time period ranging from 60 to 238 d, which was different from control heifers (P < .01). Serum progesterone for the control heifers continued to exhibit cyclic profiles over the experimental period. This preliminary study in heifers demonstrated that a chimeric LHRH fusion protein induced elevated concentrations of circulating LHRH antibodies that suppressed estrus for an average of 122 +/- 41 d.

The testosterone level has an inverse relation to activity in the open-field test. This is more important in red light than in white light. Pineal indols do not disturb this action. Some of these results are consistent with the assumption that androgens play a role on the exploratory activity of adult subjects.